EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent Advances in the Development of Pyrazole Derivatives as Anticancer Agents

Yingqian Zhang, Chenyuan Wu, Nana Zhang, Rui Fan, Yang Ye iD, Jun Xu iD

International Journal of Molecular Sciences · 12.08.2023 · 24 (16) · 12724

DOI: 10.3390/ijms241612724 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 12.08.2023. Verfasst von Yingqian Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Hangzhou Normal University, Hangzhou 311121, China. Hauptthemen laut MEDLINE: Antineoplastic Agents. Die Arbeit wurde bisher 145-mal zitiert (Crossref) und nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NFSC, Fund Committee of Zhejiang Province, Hangzhou Normal University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pyrazole derivatives, as a class of heterocyclic compounds, possess unique chemical structures that confer them with a broad spectrum of pharmacological activities. They have been extensively explored for designing potent and selective anticancer agents. In recent years, numerous pyrazole derivatives have been synthesized and evaluated for their anticancer potential against various cancer cell lines. Structure–activity relationship studies have shown that appropriate substitution on different positions of the pyrazole ring can significantly enhance anticancer efficacy and tumor selectivity. It is noteworthy that many pyrazole derivatives have demonstrated multiple mechanisms of anticancer action by interacting with various targets including tubulin, EGFR, CDK, BTK, and DNA. Therefore, this review summarizes the current understanding on the structural features of pyrazole derivatives and their structure-activity relationships with different targets, aiming to facilitate the development of potential pyrazole-based anticancer drugs. We focus on the latest research advances in anticancer activities of pyrazole compounds reported from 2018 to present.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsPyrazolesCell LineStructure-Activity RelationshipTubulin

Stichwörter der Autor:innen

anticancerapoptosiscytotoxicityinhibitorpyrazole

Substanzen

Antineoplastic AgentsPyrazolesTubulin

Autor:innen und Institutionen

  • School of Pharmacy, Hangzhou Normal University, Hangzhou 311121, China.
  • Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang Province, Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines, Engineering Laboratory of Development and Application of Traditional…
  • College of Material, Chemistry and Chemical Engineering, Key Laboratory of Organosilicon Chemistry and Material Technology, Ministry of Education, Hangzhou Normal University, Hangzhou 311121, China.

ORCID-Profile: Yang Ye, Jun Xu

Förderung

  • NFSC
  • Fund Committee of Zhejiang Province
  • Hangzhou Normal University
  • National Natural Science Foundation of China
  • Nature Science Foundation of Zhejiang Province
  • Nature Scientific Research Foundation for Scholars of Hangzhou Normal University

Zitieren

APA

Zhang, Y., Wu, C., Zhang, N., Fan, R., Ye, Y., & Xu, J. (2023). Recent Advances in the Development of Pyrazole Derivatives as Anticancer Agents. International Journal of Molecular Sciences, 24(16), 12724. https://doi.org/10.3390/ijms241612724

Vancouver

Zhang Y, Wu C, Zhang N, Fan R, Ye Y, Xu J. Recent Advances in the Development of Pyrazole Derivatives as Anticancer Agents. International Journal of Molecular Sciences. 2023;24(16):12724. doi:10.3390/ijms241612724

BibTeX
@article{Zhang2023,
  author = {Zhang, Yingqian and Wu, Chenyuan and Zhang, Nana and Fan, Rui and Ye, Yang and Xu, Jun},
  title = {Recent Advances in the Development of Pyrazole Derivatives as Anticancer Agents},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {16},
  pages = {12724},
  doi = {10.3390/ijms241612724}
}
Kostenlos starten →